SER today
$1.41-$0.09 (-6.00%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns up above $2.55
Key levels
Resistance$1.80
Resistance$1.49
Support$1.14
Latest news & SEC filings
EarningsSerina Therapeutics posts smaller quarterly loss than expected, revenue $125,000
SEC FilingSerina Therapeutics, Inc. filed a report on a major company event (Form 8-K)
All SER news →About Serina Therapeutics
Serina Therapeutics is a biotech firm in the clinic stage that creates treatments for brain and nerve disorders. It uses a polymer-based delivery system known as POZ to attach drugs to a synthetic polymer, aiming for slow release via under-the-skin shots. Its most advanced candidate, SER-252, is being tested in patients with late-stage Parkinson's disease. The company also works with partners on uses like messenger RNA medicines and antibody-drug conjugates.
Based on the company's 10-K filed Mar 25, 2026.
NYSE · Healthcare
Serina Therapeutics, Inc. (SER)
What Is the Price Target for SER?
SEPT Low Target
$8.00
SEPT Mid Target
$8.00
SEPT High Target
$8.00
Analyst Consensus
$8.00
Is SER a Buy or Sell Right Now?
Thesis
- •Revenue growing 132.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SER.
Start Free Trial →Is SER Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$8.00
30
Moat Score
NONE
2/9
Piotroski Score
-22.5
Altman Z-Score
What Is Smart Money Doing with SER?
Insider Signal
NEUTRAL
5 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| WILSON KAREN J | director | Buy | 5,000 | $9K | Jun 12, 2026 |
| WILSON KAREN J | director | Buy | 5,100 | $9K | Jun 11, 2026 |
| LEDGER STEVEN A | director officer | Buy | 10,100 | $19K | May 26, 2026 |
| WILSON KAREN J | director | Buy | 10,000 | $19K | May 22, 2026 |
| WILSON KAREN J | director | Buy | 10,000 | $18K | May 21, 2026 |
| Marshall Richard Peter | director | Buy | 12,183 | $20K | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SER Growth Story
Revenue YoY
132.1%
3yr Revenue CAGR
56.4%
EPS Growth YoY
-26.49%
FCF Growth YoY
-5.0%
Revenue Trend
STRONG
Dark Pool Trades for SER
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SER, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:36:20 | $1.43 | 2,500 | $$4K | BUY |
| 16:46:08 | $1.42 | 9,594 | $$14K | SELL |
| 16:18:17 | $1.53 | 5,000 | $$8K | BUY |
| 15:36:49 | $1.46 | 2,000 | $$3K | BUY |
| 15:12:01 | $1.42 | 2,000 | $$3K | SELL |
5 dark pool trades shown · $$31K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Serina Therapeutics, Inc. (SER) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SER — frequently asked questions
What is SER stock price today?
Serina Therapeutics, Inc. (SER) is at $1.41, down 6.00% (-$0.09) at the Nov 12, 2026 close.
Why is SER stock moving today?
Latest SER news — Nov 12, 2026: Serina Therapeutics posts smaller quarterly loss than expected, revenue $125,000 · Nov 12, 2026: Serina Therapeutics, Inc. filed a report on a major company event (Form 8-K)
What is the SER price target?
The average analyst price target for SER is $8.00, ranging from $8 to $8, based on 2 analysts.
What do analysts rate SER?
Analyst ratings for SER: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did SER beat earnings?
SER last reported on Aug 13, 2026: EPS -$0.55 vs -$0.47 expected — a miss of 17.9%.
Does SER pay a dividend?
SER does not currently pay a dividend.
What are SER support and resistance levels?
Support: $1.14. Resistance: $1.49, $1.80, $2.18.
What are insiders doing with SER?
Insider activity: NEUTRAL, 5 buys and 4 sells in the last 90 days.
What is the latest news on SER?
Nov 12, 2026: Serina Therapeutics posts smaller quarterly loss than expected, revenue $125,000 · Nov 12, 2026: Serina Therapeutics, Inc. filed a report on a major company event (Form 8-K)